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BAXinvestigated the mechanism of cytochrome c release from isolated brain
mitochondria induced by recombinant oligomeric BAX (BAXoligo). We found that BAXoligo caused a complete
release of cytochrome c in a concentration- and time-dependent manner. The release was similar to those
induced by alamethicin, which causes maximal mitochondrial swelling and eliminates barrier properties of
the OMM. BAXoligo also produced large amplitude mitochondrial swelling as judged by light scattering assay
and transmission electron microscopy. In addition, BAXoligo resulted in a strong mitochondrial depolarization.
ATP or a combination of cyclosporin A and ADP, inhibitors of the mPT, suppressed BAXoligo-induced
mitochondrial swelling and depolarization as well as cytochrome c release but did not inﬂuence BAXoligo
insertion into the OMM. Both BAXoligo- and alamethicin-induced cytochrome c releases were accompanied
by inhibition of ROS generation, which was assessed by measuring mitochondrial H2O2 release with an
Amplex Red assay. The mPT inhibitors antagonized suppression of ROS generation caused by BAXoligo but not
by alamethicin. Thus, BAXoligo resulted in a complete cytochrome c release from isolated brain mitochondria
in the mPT-dependent manner without involvement of oxidative stress by the mechanism requiring
mitochondrial remodeling and permeabilization of the OMM.
© 2008 Elsevier B.V. All rights reserved.In apoptosis, a release of mitochondrial apoptogenic proteins
occurs due to the interaction of mitochondria with pro-apoptotic
members of the Bcl-2 family such as activated (truncated) BID (tBID)
and BAX [1,2]. Monomeric BAX resides in the cytosol and remains
inactive until tBID causes its oligomerization and incorporation into
the OMM [3,4]. This leads to permeabilization of the OMM and escape
of mitochondrial apoptogenic proteins frommitochondrial intermem-
brane space [5]. In the experimental conditions, an oligomerization of
BAX can be enforced by a low concentration of mild detergents such as
octyl glucoside [1,6,7]. This oligomerized BAX (BAXoligo) also permea-
bilizes the OMM and releases cytochrome c [1,7].
In early studies, the mitochondrial permeability transition (mPT)
was implicated in protein-induced cytochrome c release as an
essential mechanism leading to mitochondrial swelling and rupture
of the OMM [8–12]. However, in our previous study with isolated
brain mitochondria, recombinant tBID alone, or in combination either
with monomeric BAX lacking C-terminal segment (BAXΔC) or with ase; OMM, outer mitochondrial
Ψ, mitochondrial membrane
Cyclosporin A; VDAC, voltage
subunit IV
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l rights reserved.full-length monomeric BAX, caused cytochrome c release, which was
not sensitive to inhibitors of the mPT [13,14]. This suggested an mPT-
independent release of cytochrome c. This conclusion is consistent
with numerous observations from different laboratories, indicating
that protein-induced cytochrome c release may occur without
involvement of the mPT [15–20]. However, it still remains unknown
whether BAXoligo causes a release of cytochrome c from brain
mitochondria in an mPT-dependent or mPT-independent manner.
The massive cytochrome c release induced by pro-apoptotic
proteins was proposed to occur in two steps including (i) cristae
remodeling, which eliminates the diffusion barrier for cytochrome c
and (ii) cytochrome c escape from the intermembrane space
following either pore formation in the OMM or the rupture of the
OMM due to matrix swelling [21]. Alternatively, the release of
cytochrome c induced by BAXoligo from liver mitochondria was
hypothesized to occur also in two steps involving loosening of
cytochrome c binding to the inner mitochondrial membrane (IMM)
due to oxidative stress and lipid peroxidation followed by its
dissociation from the membrane and escape through the permeabi-
lized OMM [22]. Later, it was proposed that cytochrome c release
during apoptotic events might occur in a single step requiring only
permeabilization of the OMM [23]. In our study, we addressed a
question whether mitochondrial remodeling and oxidative stress
play an essential role in the BAXoligo-induced cytochrome c release
from brain mitochondria.
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mitochondria, recombinant BAXoligo induces massive cytochrome c
release sensitive to a combination of cyclosporin A (CsA) and ADP, the
inhibitors of the mPT [24–26]. Moreover, we found that BAXoligo
caused large amplitude mitochondrial swelling and depolarization of
organelles, which could be suppressed by mPT inhibitors. In addition,
we found that an oxidative stress was not required for a complete
cytochrome c release produced by BAXoligo or by antibiotic alamethi-
cin, which eliminated barrier properties of the OMM [27]. Thus, our
data are consistent with the hypothesis that BAXoligo produces
complete cytochrome c release from isolated brain mitochondria in
the mPT-dependent manner by the mechanism involving mitochon-
drial remodeling but not oxidative stress.
1. Materials and methods
1.1. Recombinant BAX
Recombinant BAX was prepared and oligomerized in the dialysis
buffer containing 25 mM HEPES-NaOH, pH 7.5, 1% (w/v) octyl
glucoside, 0.2 mM dithiothreitol, 30% glycerol (v/v) as described
previously [6].
1.2. Isolation and puriﬁcation of brain mitochondria
Mitochondria from the brains or livers of male Sprague–Dawley
rats, 200–250 g (Harlan, Indianapolis, IN, USA) were isolated in
mannitol-sucrose medium according to an IACUC approved protocol
and puriﬁed on a discontinuous Percoll gradient as described
previously [27]. Mitochondrial protein was measured by the Bradford
method [28], using BSA as a standard.
1.3. Measurements of mitochondrial respiration
Mitochondrial respiration was measured in the standard incuba-
tion medium at 37°C under continuous stirring. The standard
incubation medium contained 125 mM KCl, 10 mM HEPES, pH 7.4,
0.5mMMgCl2, 3mMKH2PO4,10 μMEGTA, 0.1% bovine serum albumin
(free from fatty acids) and was supplemented either with 3 mM
succinate plus 3 mM glutamate, or with 3 mM succinate plus 1 μM
rotenone, or with 3 mM pyruvate plus 1 mM malate. The 0.3 ml
incubation chamber was equipped with a Clark-type oxygen electrode
and a tightly closed lid. The slope of the O2 electrode trace
corresponded to the respiratory rate. All data traces shown are
representative of at least three separate experiments.
1.4. Monitoring of mitochondrial membrane potential
The mitochondrial membrane potential (Δψ) was monitored by
following the distribution of TPP+ between the external medium
(initially 1.8 μM TPP+-Cl) and the mitochondrial matrix with a
TPP+-sensitive electrode [29] in the standard incubation medium
supplemented with 3 mM succinate plus 3 mM glutamate unless
stated otherwise. A decline in the external TPP+ concentration in the
medium corresponded to mitochondrial polarization, whereas a rise
in the TPP+ concentration in the medium corresponded to depolar-
ization. In all experiments with isolated mitochondria, the concen-
tration of mitochondrial protein in the chamber was 0.2 mg/ml.
All data traces shown are representative of at least three separate
experiments.
1.5. Measurements of mitochondrial light scattering
Mitochondrial swelling was evaluated in the standard incubation
medium by monitoring the scattering of light directed on mitochon-
drial suspension under 90° to the axis of the photodetector at 525 nmin a 0.4-ml cuvette under continuous stirring using a PerkinElmer
LS-55 luminescence spectrometer unless stated otherwise.
1.6. Measurements of ROS Generation
Production of ROS by isolated brain mitochondria incubated in the
standard incubation medium was assessed using the Amplex Red
assay for H2O2 (Invitrogen), as described previously [14].
1.7. Transmission electron microscopy
Electronmicroscopy of isolated brain mitochondriawas performed
as described previously [30]. Mitochondria were incubated in the
standard 125 mM KCl-based medium supplemented with 3 mM
succinate plus 3 mM glutamate at 37 °C prior to ﬁxation in 2%
paraformaldehyde and 2% glutaraldehyde in 0.05 M phosphate buffer
in the same incubation medium at room temperature for 15 min.
Samples for transmission electronmicroscopy (TEM)were taken using
a Tecnai G12 BioTwin electron microscope (FEI, Hillsboro, OR)
equippedwith an AMT 2.6×2.6 K digital CCD camera. To quantitatively
assess the morphological changes, we used the morphometric
analysis described previously [12]. Total mitochondrial population
was categorized into three groups according to their morphology as
follows: (i) condensed, (ii) mitochondria with tubular cristae, and (iii)
swollen. Mitochondria with characteristics bridging morphologic
groups were assigned to the lower category. Mitochondria were
counted in a blind fashion, and morphological distribution was
statistically analyzed using a one-way analysis of variance followed
by Bonferroni's posttest (GraphPad Prism, 4.0).
1.8. BAX insertion
To determine alkali-resistant fraction of BAX inserted into the
OMM the earlier described method was used (Roucou et al. 2002a).
Brieﬂy, mitochondria treated with BAXoligo (10.8 μg/ml) at 37 °C for
30 minwere pelleted at 15,800 g for 5 min, and supernatant was used
for the cytochrome c release measurements. Mitochondrial pellets
were re-suspended in 0.2 ml of 0.1 Na2CO3, pH 11.5, and incubated for
20 min on ice. Samples were centrifuged for 25 min at 100,000 g in
Sorvall Ultra Pro® 80 ultracentrifuge. The pellets were solubilized
using 2% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesul-
fonate (CHAPS) and analyzed by western blotting against BAX and
cytochrome oxidase subunit IV (COX IV).
1.9. Immunoblotting
The release of cytochrome c from isolated brain mitochondria was
assessed using western blotting in supernatants obtained through
incubation of mitochondria in the standard 125 mM KCl-based
incubation medium for 30 min at 37 °C. For electrophoresis, we
used 4–12% Bis–Tris gels (Invitrogen, Carlsbad, CA). Western blotting
was performed as previously described [14]. The release of cyto-
chrome c from mitochondria treated with alamethicin (30 μg/ml) was
used as a control for maximal cytochrome c release. For detection of
Smac/DIABLO, AIF, Omi/HtrA2, and Endo G the supernatants were
concentrated 6 fold by using Microcon YM-10 ﬁltering de-
vices (Millipore Corporation, Bedford, MA). Mitochondrial voltage-
dependent anion channel (VDAC) or COX IV were used as a loading
control for the pellet samples. VDAC was detected with goat
polyclonal anti-VDAC antibody, dilution 1:200 (Santa Cruz Biotech-
nology, Santa Cruz, CA). COX IV was detected with mouse mono-
clonal anti-COX IV antibody, dilution 1:5000 (Invitrogen, Carlsbad,
CA). Following electrophoresis proteins were transferred to
Hybond™-ECL™ nitrocellulose membrane (Amersham Biosciences,
Piscataway, NJ) and blots were incubated with primary mouse anti-
cytochrome c antibody (7H8.2C12, PharMingen, San Diego, CA) at
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Diego, CA) at 1:500, anti-EndoG antibody (Oncogene, San Diego, CA) at
1:1000, rabbit anti-Omi/HtrA2 antibody (R and D Systems, Minnea-
polis, MN) at 1:1000 or rabbit anti-AIF antibody (R and D Systems,
Minneapolis, MN) at 1:2000 dilution for an hour at room temperature
in 5% non-fat milk, phosphate-buffered saline, pH 7.2, and 0.15% Triton
X-100. In the BAXoligo insertion experiments, BAX was detected with
rabbit anti-BAX antibody (Upstate, Lake Placid, NY) used at 1:2000
dilution. Blots were developed using goat anti-rabbit and anti-mouse
IgG (1:20,000) coupled to horseradish peroxidase (Jackson ImmunoR-
esearch Laboratories, West Grove, PA) and Supersignal West chemi-
luminescent reagents (Pierce, Rockford, IL). Molecular weight marker
SeeBlue® Plus 2 Standards (5 μl), (Invitrogen, Carlsbad, CA) were used
to determine molecular weights of the bands.
1.10. Statistics
Statistical analyses of experimental data consisted of a one-way
analysis of variance followed by Bonferroni's posttest (GraphPadFig. 1. Exogenous cytochrome c did not inﬂuence respiration of isolated brain mitochondria.
with 3mM succinate plus 3mM glutamate (a) or with 3mMpyruvate plus 1mMmalate (b). C
Where indicated, 200 μMADP or 60 μM2,4-dinitrophenol (2,4-DNP)were added. Panel c showPrism, version 4.0; GraphPad Software, San Diego, CA). The data
represent the mean±S.E. of at least three separate, independent
experiments.
2. Results
Since during isolation and puriﬁcation procedure the outer
mitochondrial membrane (OMM) could be damaged, we ﬁrst analyzed
the intactness of the OMM in our mitochondrial preparations. Fig. 1
shows measurements of mitochondrial respiration performed with
and without exogenous cytochrome c. The lack of cytochrome c effect
in these experiments indicated intactness of the OMM in the majority
of mitochondria. This was also supported by the fact that isolated
brain mitochondria used in our study retained their structural
integrity and released minimal amounts of cytochrome c during
incubation in the standard incubation medium at 37 °C for 30 min
(Fig. 2). An addition of BAXoligo to mitochondria caused cytochrome c
release in a concentration- and time-dependent fashion. The release of
cytochrome c became evident with as low as 1.8 μg/ml BAXoligoMitochondria were incubated in the standard incubation medium supplemented either
ytochrome c (+Cyt c, 50 μM)was present in themedia prior to addition of mitochondria.
s statistical analysis of respiratory rates obtainedwith andwithout 50 μMcytochrome c.
Fig. 2. Recombinant oligomeric BAX (BAXoligo) triggered cytochrome c release from
isolated brain mitochondria in a time- and concentration-dependent manner. In a, a
concentration-dependence of BAXoligo-induced cytochrome c release is shown.
Mitochondria were incubated under very gentle shaking for 30 min at 37 °C with the
indicated concentrations of BAXoligo. Here and in other experiments, western blots
obtained with solubilized pellets and anti-VDAC antibody were used as loading
controls. Here and in other similar experiments, an aliquot (6 μl added into 300 μl of the
incubation medium) of the dialysis buffer containing 1% octyl glucoside was used as a
vehicle. In d, a time-dependence of BAXoligo-induced cytochrome c release is shown.
10.8 μg/ml BAXoligo was applied to isolated brain mitochondria for the time indicated. In
b and e, columns show the results of densitometry produced with Quantity One®
software (Bio-Rad Laboratories, Hercules, CA) and expressed in arbitrary units (a.u.) for
the corresponding bands. In c and f, the statistical analyses of densitometry results are
shown as percentage of cytochrome c release. In c, cytochrome c release with
alamethicin was taken as 100%. In f, cytochrome c release after 30 min of incubation
with BAXoligo was taken as 100%.
Fig. 3. Detection of Smac/DIABLO, AIF, Omi/HtrA2 and Endonuclease G (Endo G) in the
supernatants obtained after incubation of brain mitochondria with BAXoligo. Mitochon-
dria were incubated under very gentle shaking for 30 min at 37 °C with 10.8 μg/ml
BAXoligo or with 30 μg/ml alamethicin. Endo G was not detected in the supernatant even
after incubation of mitochondria with alamethicin. The total amount of Smac/DIABLO,
AIF, Omi/HtrA2 and Endo G was determined in the same amount of mitochondria
(solubilized Mtc) used in the “release” experiments.
Fig. 4. BAXoligo caused complete cytochrome c release in high-ionic strength KCl-based
medium but not in low-ionic strength mannitol-sucrose incubation medium. BAXoligo
producedmitochondrial swelling and depolarization in mannitol-sucrose medium. In a,
the results of western blotting. Brain mitochondria were incubated with 10.8 μg/ml
BAXoligo for 30 min at 37 °C either in the standard 125 mM KCl-based incubation
medium or in the incubation medium where KCl was replaced for 215 mM mannitol
plus 70 mM sucrose (MS). In b and c, in mannitol-sucrose medium BAXoligo (10.8 μg/ml)
induced mitochondrial swelling and depolarization in CsA, ADP-sensitive manner. In
these experiments mitochondrial swelling and membrane potential were monitored
simultaneously by following changes in light scattering at 180° (thick traces) and
distribution of TPP+ between external medium and mitochondrial matrix (thin traces).
Two pairs of light scattering traces, indicative of changes in mitochondrial volume, and
TPP+ traces, indicative of changes in mitochondrial membrane potential, obtained with
and without 1 μM CsA and 100 μM ADP (plus 1 μM oligomycin) are overlapped for
comparison. At the end of the experiments 267 μM Ca2+ was added to induce Ca2+-
dependent permeability transition.
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chrome c release, culminating at 10.8 μg/ml of BAXoligo. At this
concentration, BAXoligo released the entire cytochrome c similar to
alamethicin, an antibiotic which completely eliminated barrier
properties of the OMM [27] and induced maximal cytochrome c
release (Fig. 2a). Consistent with this, the amount of cytochrome c
remaining in the corresponding mitochondrial pellets appeared to be
below the detection limit of western blotting. Here and in other
similar experiments, detection of VDAC in the pellets with anti-VDAC
antibody ensured equal sample loading. Cytochrome c release induced
by 10.8 μg/ml of BAXoligo occurred in a time-dependent manner and
1413T. Li et al. / Biochimica et Biophysica Acta 1777 (2008) 1409–1421was completed within 30 min (Fig. 2b). Figs. 2c and f show statistical
analyses of cytochrome c release induced by BAXoligo.
In parallel with cytochrome c release, BAXoligo induced a massive
release of Smac/DIABLO while Endo G was released neither after
BAXoligo nor after alamethicin treatment (Fig. 3). With anti-Omi/HtrA2
antibody we detected faint bands in the supernatants obtained after
incubation of mitochondria with BAXoligo or alamethicin (Fig. 3). With
anti-AIF antibody, we detected two bands in the supernatants
obtained after incubation of mitochondria with BAXoligo and three
bands after incubation with alamethicin (Fig. 3). In the experiments
with AIF release measurements we incubated mitochondria without
BSA because BSA interferes with AIF detection [30]. While the major,
thick band detected with the supernatant sample after alamethicin
treatment might belong to AIF, the two faint bands detected with the
supernatants obtained after incubation of mitochondria with BAXoligo
or alamethicin might represent products of AIF cleavage. To estimate
the extent of the protein release, the same amount of brain
mitochondria used in the “release” experiments was solubilized and
analyzed by western blotting. These estimations revealed that the
total amount of AIF and Omi/HtrA2 signiﬁcantly exceeded the amountFig. 5. Rotenone, a combination of cyclosporin A and ADP, or ATP inhibited cytochrome c rele
a, c, and e, brain mitochondria were treated with vehicle (6 μl of dialysis buffer for BAXoligo
7.2 μg/ml BAXoligo (c), or with 30 μg/ml alamethicin (Alam) under very gentle shaking for 30 m
3 mM glutamate (S+G) or with 3 mM succinate and 1 μM rotenone (Rot, S+R) as indicate
cyclosporin A (CsA) and 100 μM ADP (plus 1 μM oligomycin) (panel a, e) or with 1 mM A
oligomycin in minutes. Panels b, d, and f show statistical analyses of cytochrome c release in
100%. In b, ⁎pN0.05 between the BAXoligo-induced cytochrome c release in the experiments
the BAXoligo-induced cytochrome c release with andwithout CsA, ADP, and oligomycin. In d, ⁎
⁎pb0.05, ⁎⁎pb0.01 between the effect of vehicle and BAXoligo, N=3. In g, mitochondria were
BAXoligo insertion was evaluated as described in Materials and Methods. Where indicated, m
oligomycin). COX IV immunoblots were used as a control for equal loading.of these proteins detected in the supernatants after incubation of
mitochondria with BAXoligo. Thus, the release of AIF and Omi/HtrA2
induced by BAXoligo was miniscule in comparison with a complete
release of cytochrome c and Smac/DIABLO.
Replacement of the standard KCl-based incubationmedium for the
low-ionic strength, mannitol-sucrose (MS) medium completely pre-
vented BAXoligo-induced cytochrome c release (Fig. 4). Similar results
were obtained with alamethicin (not shown). In mannitol-sucrose
medium BAX induced mitochondrial swelling and depolarization in
CsA, ADP-sensitive manner (Figs. 4b,c). Thus, the lack of cytochrome c
release in mannitol-sucrose medium cannot be explained by the
absence of the mPT under these conditions. These observations
suggest that in brain mitochondria, cytochrome c attachment to the
IMM appears to be primarily due to an electrostatic interaction
between cytochrome c and the inner mitochondrial membrane (IMM)
in agreement with early reports [31,32].
The release of cytochrome c from mitochondria incubated with
succinate plus rotenone appeared to be smaller than the release from
mitochondria fueled with succinate plus glutamate (Fig. 5a). It is
known that rotenone suppresses the mPT by maintainingase induced by BAXoligo but did not inﬂuence BAX insertion into the outer membrane. In
solubilization added into 300 μl of the standard incubation medium), with 10.8 (a,e) or
in at 37 °C. The incubation mediumwas supplemented either with 3 mM succinate and
d. In addition, where indicated the incubation medium was supplemented with 1 μM
TP (panel c). In e, numbers show the time of incubation with BAXoligo, CsA, ADP and
different conditions. In all cases, cytochrome c release with alamethicin was taken as
with succinate plus glutamate versus succinate plus rotenone, N=5; ⁎⁎pN0.01 between
pb0.05 between BAXoligo-induced cytochrome c release with and without ATP, N=5. In f,
incubated under very gentle shaking for 30 min at 37 °C with 10.8 μg/ ml BAXoligo. Then,
itochondria were incubated with 1 μM cyclosporin A (CsA) and 100 μM ADP (plus 1 μM
Fig. 6. In brain mitochondria BAXoligo induced large amplitude mitochondrial swelling
sensitive to the inhibitors of the mPT. In a, b, d, and e, the standard incubation medium
was supplemented with 3 mM succinate plus 3 mM glutamate; in c- with 3 mM
succinate plus 1 μM rotenone (Rot). In a, 8 μl of the dialysis buffer for BAXoligo
solubilization (vehicle) was added as indicated into a cuvette with a total volume of
400 μl of the incubation medium. In b–e, 10.8 μg/ml BAXoligo was added as indicated. In
all experiments, 30 μg/ml alamethicin was added at the end of recordings to obtain
maximal swelling. In d, the incubation medium was supplemented with 1 μM
cyclosporin A (CsA), 100 μM ADP, and 1 μM oligomycin. In e, the incubation medium
was supplemented with 1 mM ATP. In f, a graph summarizing assessments of
mitochondrial swelling is presented. The maximal amplitude of a decrease in light
scattering was assumed to reﬂect the maximal mitochondrial swelling taken as 100%
(see in panel b). The extent of mitochondrial swelling induced by BAXoligo was
calculated as a percentage of the maximal swelling. ⁎pN0.01 between the effect of
vehicle and BAXoligo in the experiments with succinate plus glutamate; #pN0.05
between the effect of BAXoligo with succinate plus glutamate and with succinate plus
rotenone; ##pN0.01 for the effect of BAXoligo with or without CsA, ADP, and oligomycin,
and for the effect of BAXoligo with or without ATP (N=3).
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Therefore, the mPTmight be involved in BAXoligo-induced cytochrome
c release from brain mitochondria as it was demonstrated earlier for
liver mitochondria [9,36]. Indeed, a combination of CsA and ADP,
inhibitors of the mPT [24–26], signiﬁcantly diminished cytochrome c
release induced by BAXoligo (Fig. 5a). Here and in all other
experiments, ADP was used in the presence of 1 μM oligomycin to
prevent ADP phosphorylation. The time-dependence of BAXoligo-
induced cytochrome c release in the presence of CsA and ADP is
shown in Fig. 5e. In the parallel experiments, CsA and ADP did not
inﬂuence BAXoligo insertion into the OMM (Fig. 5g) suggesting that
BAXoligo insertion did not require the mPT. Of note, the amount of
endogenous BAX in naive brainmitochondriawas below the detection
limit of western blot (Fig. 5g). ATP, another inhibitor of the mPT [37],
also attenuated cytochrome c release induced by BAXoligo (Fig. 5b) but
did not inﬂuence BAXoligo insertion (not shown). Alamethicin-induced
release of cytochrome c was insensitive to mPT inhibitors (Fig. 5a–d).
Fig. 5b, d, and f show statistical analyses of cytochrome c release. Thus,
suppression of BAXoligo-induced cytochrome c release by inhibitors of
the mPT suggested involvement of the mPT in this process.
In addition to cytochrome c release, BAXoligo resulted in a large
amplitude swelling of brain mitochondria as judged by the decrease in
light scattering of mitochondrial suspension measured at 90° to the
incident beam (Fig. 6). Alamethicin produced a maximal decrease in
light scattering corresponding to the maximal extent of mitochondrial
swelling [27]. To compare different light scattering experiments, we
assumed the maximal swelling produced by alamethicin as 100% and
estimated the extent of swelling produced by BAXoligo under different
conditions as a percentage from the maximal swelling (X%) (Fig. 6b).
An aliquot of the dialysis buffer used for oligomerization of BAXoligo
and containing 1% octyl glucoside failed to produce signiﬁcant change
in light scattering (Fig. 6a). BAXoligo caused the largest decrease in light
scattering when mitochondria were fueled with succinate plus
glutamate (Fig. 6b), while with succinate plus rotenone the decrease
in light scattering was smaller (Fig. 6c). Importantly, a combination of
cyclosporin A and ADP suppressed the mitochondrial swelling
induced by BAXoligo (Fig. 6d). Similar effect was obtained with 1 mM
ATP (Fig. 6e). Fig. 6f summarizes the results of the light scattering
measurements. Thus, BAXoligo induced a large amplitude mitochon-
drial swelling sensitive to the mPT inhibitors, suggesting mPT
involvement.
To further examine mitochondrial morphological changes, we
performed transmission electron microscopy (TEM) with isolated
brain mitochondria treated with BAXoligo (Fig. 7). All mitochondria
were divided in three morphological classes including condensed (C),
swollen (S), and mitochondria with tubular cristae (T) shown in
Fig. 7a, b, and c respectively. The results of morphometric analysis
performed in a blind manner are shown in Fig. 7g. A vast majority of
organelles treated with the vehicle appeared to be in the condensed
state with a signiﬁcant vacuolization of matrices (Fig. 7d) typical for
the isolated brain mitochondria [13,27,38]. Treatment of mitochondria
with BAXoligo caused swelling of organelles (Fig. 7e). A few
mitochondria had particular matrix structures, which we deﬁned as
tubular cristae (Fig. 7c). Pretreatment of mitochondria with mPT
inhibitors prevented mitochondrial swelling (Fig. 7f). However,
mitochondria did not retain their initial morphology. With mPT
inhibitors, the tubular conﬁguration of cristae appeared to be
prevalent (Fig. 7f). Thus, BAXoligo caused a dramatic mitochondrial
remodeling, which was sensitive to mPT inhibitors and, therefore,
might involve the mPT.
The release of cytochrome c (Fig. 2d–f) occurred much longer after
the onset of the mPT induced by BAXoligo (Fig. 6b). To examine
whether cytochrome c release correlated with the time course of
tubular cristae formation, we performed additional electron micro-
scopy evaluation of mitochondrial morphology over time following
BAXoligo addition (Fig. 8). We found that tubular cristae were formedalready after 2 min of incubation with BAXoligo (Fig. 8c). Then, over
time the number of mitochondria with tubular cristae declined and
number of swollen mitochondria increased. Thus, BAXoligo-induced
cytochrome c release did not correlate with the time course of tubular
cristae formation and rather paralleled mitochondrial swelling.
However, this does not rule out an important role of tubular cristae
formation as a step in structural re-arrangement of mitochondria
leading to complete cytochrome c release.
In addition to the release of cytochrome c and large amplitude
swelling, BAXoligo resulted in mitochondrial depolarization in the
concentration-dependent manner (Fig. 9a,d,g). In contrast to depola-
rization induced by a combination of tBID andmonomeric BAX [13,14],
depolarizations induced by BAXoligo were abrupt and profound. At the
end of the experiments, mitochondria were treated with Ca2+ to
induce the Ca2+-dependentmPTand completely depolarize organelles.
Fig. 7. The changes in mitochondrial morphology induced by BAXoligo visualized by transmission electron microscopy with isolated brain mitochondria. The effect of cyclosporin A
and ADP. Three distinct types of mitochondrial morphology were identiﬁed: condensed (C, representative mitochondria are shown in panel a), swollen (S, representative
mitochondria are shown in panel b), and mitochondria with tubular cristae (T, representative mitochondria are shown in panel c). In d, mitochondria were treated with a vehicle (6 μl
of the dialysis buffer for BAXoligo in 300 μl of incubation medium) under very gentle shaking for 30 min at 37 °C. In e, mitochondria were treated with 10.8 μg/ml BAXoligo. In f,
mitochondriawere pre-treatedwith 1 μMcyclosporin A (CsA) and 100 μMADP plus 1 μMoligomycin for 3min prior to the addition of 10.8 μg/ml BAXoligo, towhichmitochondriawere
incubated for the next 30 min. In g, the results of morphometric analysis are expressed as a percentage from the total number of analyzed mitochondria. Mitochondria were counted
in a blind manner, the total number of mitochondria per conditionwas 550–600. ⁎pN0.05, ⁎⁎pN0.01 for the corresponding types of mitochondria after treatment with vehicle versus
BAXoligo; #pN0.05, ##pN0.01 for the corresponding types of mitochondria after treatment with BAXoligo in the presence or absence of CsA, ADP, and oligomycin.
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suppressed depolarizations induced by BAXoligo (Fig. 9c,f,i). The mPT
inhibitors also protected against Ca2+-induced sustained depolarization,
but only in the experiments in which Ca2+ was added after low or
moderate BAXoligo (3.6 or 7.2 μg/ml). With a high BAXoligo (10.8 μg/ml),
the inhibitors of the mPT failed to preclude sustained depolarization
induced by Ca2+ (Fig. 9h,i), probably due tomassive loss of cytochrome c
(Fig. 2) and impaired capacity of the respiratory chain. Thus, in addition
to the cytochrome c release and mitochondrial swelling, brain
mitochondria responded to BAXoligo by depolarization, which appeared
to be sensitive to mPT inhibitors and, therefore, associated with the
induction of the mPT.
The large amplitude swelling of isolated brain mitochondria
produced by BAXoligo might lead to the rupture of the OMM, which
subsequently would result in a cytochrome c escape from the
intermembrane space [27,39]. Alternatively, BAXoligo could speciﬁcally
permeabilize the OMM. In order to evaluate the role of mitochondrial
swelling in the OMM permeabilization, we compared mitochondrial
swelling and the release of cytochrome c induced by BAXoligo or a
bolus of Ca2+. Previously, we have shown that in the standard 125 mM
KCl-based incubation medium, isolated brain mitochondria undergo
large amplitude swelling without substantial release of cytochrome c
[27]. Similar observation has been made by other investigators withmitochondria isolated from Xenopus eggs [16]. It was concluded that
under these circumstances the extent of swelling appeared to be
insufﬁcient to rupture the OMM and release cytochrome c [16,27]. We
conﬁrmed these ﬁndings in the present study. Indeed, with all tested
oxidative substrates, Ca2+ produced a signiﬁcant decrease in light
scattering of mitochondrial suspension, indicative of mitochondrial
swelling, which was comparable with a decrease in light scattering
produced by BAXoligo (compare Figs. 6b,c and 10a–c). This suggested
similar swelling of organelles treated with BAXoligo or Ca2+. Indeed,
TEM conﬁrmed that a signiﬁcant fraction ofmitochondria treatedwith
Ca2+ appeared to be swollen similar to mitochondria treated with
BAXoligo (compare Figs. 7e and 10f). However, Ca2+, in contrast to
BAXoligo, did not produce a detectable cytochrome c release (Fig. 10h)
while BAXoligo caused a massive release of cytochrome c (Fig. 2). Thus,
it seems likely that in addition to mitochondrial swelling and possible
rupture of the OMM, which we cannot rule out, BAXoligo causes
dramatic permeabilization of the OMM by another as yet unidentiﬁed
mechanism.
The results presented so far indicate that in isolated brain
mitochondria BAXoligo induces cytochrome c release that parallels an
induction of the mPT. Ca2+ is the most prominent inducer of the mPT
[21]. Without additional testing, we could not rule out that calcium
might contaminate BAXoligo preparations used in our experiments. To
Fig. 8. Time-dependence of BAXoligo-induced morphological changes in brain mitochondria. In a, mitochondria were treated with a vehicle (6 μl of the dialysis buffer for BAXoligo in
300 μl of incubation medium) under very gentle shaking for 30min at 37 °C. In b–f, brainmitochondriawere ﬁxed after 30 s, 2, 5, 15 and 30min of incubationwith 10.8 μg/ml BAXoligo,
respectively. In g, the results of morphometric analysis are expressed as a percentage from the total number of analyzed mitochondria. C, condensed mitochondria; S, swollen
mitochondria; T, mitochondria with tubular cristae. Mitochondria were counted similar as described in the legend to Fig. 7. ⁎pN0.05 and ⁎⁎pN0.01, #pN0.05 and ##pN0.01, †pN0.05
and ††pN0.01 for the corresponding types of mitochondria after treatment with vehicle versus BAXoligo.
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preparation using the Ca2+-selective electrode (Fig. 11a). These
experiments revealed that BAXoligo preparations used in our experi-
ments did not contain appreciable amounts of Ca2+. Nevertheless, we
examined the cytochrome c release induced by BAXoligo in the
presence of 1 mM EGTA and did not ﬁnd any difference withexperiments where we used 10 μM EGTA (Fig. 11b). Thus, all data
obtained with recombinant BAXoligo could be attributed to the action
of this protein and to Ca2+ contamination.
Earlier, it was proposed that oxidative stress and lipid peroxidation
could contribute to BAXoligo-induced cytochrome c release from
isolated liver mitochondria [22]. In the following experiments, we
Fig. 9. In isolated brainmitochondria BAXoligo causedmitochondrial depolarization sensitive to the inhibitors of themPT. Different concentrations of BAXoligo were added as indicated.
At the end of the experiments, 267 μM Ca2+ was added to completely depolarize mitochondria. In b, e, and h, the incubation medium was supplemented with 1 μM cyclosporin A
(CsA), 100 μM ADP, and 1 μM oligomycin. In c, f, and i, the incubation medium was supplemented with 1 mM ATP. In the control experiments, an aliquot of the dialysis buffer for
BAXoligo with 1% octyl glucoside (6 μl added into a 300 μl of the incubation medium) failed to affect mitochondrial membrane potential (not shown).
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judged as the rate of ROS generation by mitochondria, correlated with
the release of cytochrome c induced by BAXoligo or alamethicin. In
mitochondria, superoxide radical O2−U, a primary reactive oxygen
species, is converted by Mn-superoxide dismutase into H2O2 which
can be easily followedwith Amplex Red assay [40].With succinate as a
substrate, mitochondrial generation of ROS is linked to the reverse
electron ﬂow from Complex II to Complex I of the respiratory chain
and can be effectively inhibited by mild mitochondrial depolarization
[41,42]. In our experiments, BAXoligo decreased the rate of ROS
generation in a concentration-dependent manner (Fig. 12), according
to its ability to depolarize mitochondria (Fig. 9). FCCP and alamethicin
produced even stronger suppression of ROS generation. CsA and ADP
attenuated inhibition of ROS generation by BAXoligo (Fig. 12), but not
by FCCP or alamethicin (not shown). A combination of CsA and ADP
attenuated the inhibition of ROS generation by BAXoligo presumably
due to protection of Δψ and, therefore, preservation of the reverse
electron ﬂow in the respiratory chain. In the presence of mPT
inhibitors, ROS generation was high (Fig. 12), but the release of
cytochrome cwas signiﬁcantly diminished (Fig. 5). On the other hand,
mPT inhibitors failed to affect the inhibition of ROS generation
induced by alamethicin (not shown). Thus, in our experiments with
isolated brain mitochondria the intensity of oxidative stress and the
release of cytochrome c induced by BAXoligo or alamethicin had an
inverse correlation. Therefore, it seems unlikely that lipid peroxida-
tion associated with the oxidative stress contributed to the release of
cytochrome c from isolated brain mitochondria.
3. Discussion
The release of mitochondrial intermembrane proteins plays a key
role in execution of the apoptotic program [43]. The cell-freeexperimental model of isolated mitochondria in conjunction with
the use of recombinant pro-apoptotic proteins proved to be a very
helpful tool in the elucidation of these mechanisms. However, most
studies have been performedwith livermitochondria [1,9,12,22,36,44]
whereas the interaction of pro-apoptotic proteins with isolated brain
mitochondria has been less studied [13,14,19,45]. As with any model
system, results obtained with isolated mitochondria have some
limitations and cannot be applied directly to situation in the cell.
However, the experiments with whole cells often suffer from
ambiguity based on less than ideal experimental approaches,
difﬁculty to control intracellular environment, and enormous com-
plexity of cell organization at structural and biochemical levels.
Therefore, we strongly believe that preparations of isolated puriﬁed
mitochondria represent an excellent model system, which allows
precise control over experimental conditions and, thus, signiﬁcantly
facilitates detailed dissection of molecular mechanisms of mitochon-
drial involvement into apoptotic program.
The main ﬁnding of our study with isolated brain mitochondria is
that recombinant BAXoligo induces massive cytochrome c release by
the mechanism associated with the mPT but without involvement of
oxidative stress. Several different lines of experimental evidence
support this conclusion. First, BAXoligo produced cytochrome c release,
which was suppressed by inhibitors of the mPT. Second, BAXoligo
produced large amplitude mitochondrial swelling, which was also
inhibited by mPT inhibitors. Third, BAXoligo caused abrupt and
profound mitochondrial depolarization that was antagonized by
mPT inhibitors. Fourth, BAXoligo led to the inhibition of ROS generation
and mPT inhibitors attenuated inhibition of ROS generation by
BAXoligo. Finally, cytochrome c release induced by BAXoligo had an
inverse correlation with the rate of ROS generation. Thus, it appeared
that in the experiments with brain mitochondria BAXoligo resulted in
both the mPT and complete cytochrome c release, which was
Fig. 10. In the standard 125 mM KCl-based incubation medium, Ca2+ induced mitochondrial swelling but not the release of cytochrome c. In a–d, the results of light scattering assays
are shown. Mitochondria were incubated in the media with different oxidative substrates as indicated. 267 μM Ca2+ and 30 μg/ml alamethicin were added as indicated. The extent of
mitochondrial swelling was assessed as described in the legend to Fig. 3. In d, ⁎pN0.05 for the effect of Ca2+ in the experiments with succinate plus glutamate and with succinate plus
rotenone, N=3. In e–g, the results of transmission electron microscopy are shown. In these experiments, mitochondria were incubated in the standard incubation medium
supplemented with 3mM succinate and 3mM glutamate. In e and f, mitochondria were incubated under very gentle shaking for 30 min at 37 °C. In f, mitochondria were treated with
267 μM Ca2+. In g, a graph summarizing estimations of mitochondrial swelling similar to those described in the legend to Fig. 7. ⁎pN0.01 for the corresponding types of mitochondria
prior to and after treatment with Ca2+. In h, western blot analysis of cytochrome c release from mitochondria treated with 267 μM Ca2+ or 30 μg/ml alamethicin. In i, the statistical
analysis of cytochrome c release induced by Ca2+. Cytochrome c release with alamethicin was taken as 100%.
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require oxidative stress.
In early studies with isolated liver mitochondria, BAXoligo was
found to be able to cause cytochrome c release associated with the
mPT [9,11,36,46]. Correspondingly, it was hypothesized that cyto-
chrome c release occurred as a result of mitochondrial swelling and
the rupture of the OMM. Some investigators proposed that the mPT
played a regulatory role in facilitating BAX translocation into the
membrane [47] or in promoting a protein-induced efﬂux of cyto-
chrome c into the intermembrane space by remodeling mitochondrial
cristae [12]. On the other hand, a large group of investigators failed to
demonstrate a link between the protein-induced cytochrome c release
and the mPT [1,13,14,16,19,44,48]. For instance, in rat liver mitochon-
dria, BAXoligo neither induced the mPT nor preventing the mPT with
EGTA attenuated cytochrome c release induced by BAXoligo [44]. Later,
another group of investigators showed independence of BAXoligo-
induced cytochrome c release from the mPT using isolated liver
mitochondria from cyclophilin D-knockoutmice [49]. Thus, in isolated
liver mitochondria, BAXoligo did not induce the mPT, and BAXoligo-
induced cytochrome c release from liver mitochondria appeared to be
mPT-independent.The reasons for discrepancies in results from different groups are
not clear but variations in the properties of mitochondrial prepara-
tions, in the experimental protocols and in the activity of recombinant
BAXoligo might contribute to this controversy. The elusive nature of
CsA inhibition of the mPT [50] as well as our limited knowledge about
molecular composition and the mechanisms of induction of the mPT
[51,52] obviously also contribute to this problem. To identify mPT
induction in our experiments, we used ATP or a combination of CsA
and ADP, whichwere previously found to be themost effectiveways to
inhibit the mPT [25,27]. With the use of these inhibitors, we clearly
demonstrated that BAXoligo induces mPT in isolated brain mitochon-
dria and that mPT is involved in cytochrome c release induced by
BAXoligo.
ThemPT is considered a process of induction/activation of the huge
proteinaceous pore that increases the permeability of the IMM up to
1.5 kDa [37]. Ca2+ is the most prominent inducer of the pore. Although
it is known that Ca2+ has to enter mitochondria in order to induce the
mPT, the precise Ca2+ targets and the mechanisms leading to the mPT
is still not quite clear [21,52]. Ca2+, however, is not the only inducer of
the mPT. There are number of agents and factors that can also lead to
induction of the mPT in the absence of Ca2+ [10,12,46,53]. In our
Fig. 11. Preparation of BAXoligo did not contain appreciable amounts of Ca2+. BAXoligo
induced similar cytochrome c release in the incubation media supplemented with
10 μM or 1 mM EGTA. In a, a representative trace obtained with a Ca2+-sensitive
electrode. Where indicated, 10 μM EGTA, 10.8 μg/ml BAXoligo or 25 μM Ca2+ were added.
In b, cytochrome c release from brain mitochondria induced by 10.8 μg/ml BAXoligo or
30 μg/ml alamethicin in the incubation media supplemented either with 10 μM or with
1 mM EGTA. Respiratory substrates: 3 mM succinate plus 3 mM glutamate.
Fig. 12. Recombinant BAXoligo, FCCP or alamethicin inhibited ROS generation by isolated
brain mitochondria. Cyclosporin A and ADP attenuated the BAXoligo-induced inhibition
of ROS generation. In a, the representative traces obtained under different experimental
conditions are shown as: 1 — vehicle plus 1 μM cyclosporin A (CsA), 100 μM ADP, and
1 μM oligomycin (Oligo); 2 — 3.6 μg/ml BAXoligo, CsA, ADP, and Oligo; 3 — vehicle; 4 —
7.2 μg/ml BAXoligo, CsA, ADP, Oligo; 5 — 3.6 μg/ml BAXoligo; 6 — 7.2 μg/ml BAXoligo; 7 —
1 μM FCCP; 8 — 30 μg/ml alamethicin. All additions were made prior to the
mitochondria. 5.5 μl of the dialysis buffer for BAXoligo solubilization was used as a
vehicle. In b, a graph summarizes the data obtained with the Amplex Red assay under
different experimental conditions. The concentration of BAXoligo is given in μg/ml.
⁎pN0.05, ⁎⁎pN0.01 for H2O2 generation after treatment with vehicle versus treatment
with BAXoligo or alamethicin, N=3.
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large amplitude swelling of organelles, both typical features of the
mPT [54]. These effects of BAXoligo were sensitive to mPT inhibitors.
Based on these observations, we concluded that BAXoligo induced mPT
in isolated brain mitochondria. Since these experiments were
performed in the absence of Ca2+, we concluded that BAXoligo-induced
mPT was Ca2+-independent.
An inhibition of the mPT strongly attenuated cytochrome c release
induced by BAXoligo in our experiments. Thus, induction of the mPT
and mitochondrial remodeling appeared to be important for BAXoligo-
induced cytochrome c release. The most straightforward model posits
themPT-associatedmitochondrial swelling as amechanism of rupture
of the OMM, leading to escape of cytochrome c from the intermem-
brane space [39,55,56]. In our experiments, Ca2+ also induced swelling
of brain mitochondria, but failed to release cytochrome c. It is
conceivable that under these experimental conditions Ca2+-induced
swelling was insufﬁcient to rupture the OMM. Contrariwise, BAXoligo
produced mitochondrial swelling similar to Ca2+, but resulted in a
complete cytochrome c release. This suggested either a larger
amplitude of swelling or an additional, more speciﬁc mechanism of
OMM permeabilization, independent from swelling. Since TEM
images of BAXoligo- and Ca2+-treated mitochondria look strikingly
similar, the latter explanation seems more likely.
If BAXoligo can permeabilize the OMM independently from
swelling, then, the next question is how could an inhibition of the
mPT and suppression of swelling diminish the release of cytochrome
c? One plausible explanation consists in the assumption that BAXoligo
induces mPT-dependent remodeling of mitochondria, manifested in
unfolding of mitochondrial cristae, providing opening of the closed
spaces limited by cristae and, thus, facilitating escape of cytochrome c.
This could be better understood by keeping in mind that intra-cristae
regions may contain up to 85% of the total cytochrome c, whereas only
about 15% is contained in the intermembrane space [57]. Thus, by
wrapping matrix regions, cristae could restrict free diffusion of
cytochrome c. This hypothesis was proposed earlier for interaction
of tBID with isolated liver mitochondria [12]. In this study, tBID caused
distinct mitochondrial remodeling, which could be attenuated by CsAand therefore linked to the mPT [12]. Interestingly, tBID applied to
mouse liver mitochondria led to a prevalent appearance of mitochon-
dria with tubular cristae similar to those observed in our experiments
with BAXoligo and mPT inhibitors. In our experiments, most of the
brain mitochondria treated with BAXoligo in the absence of mPT
inhibitors appeared to be swollen and only a few had tubular cristae. It
is conceivable that in our experiments an inhibition of the mPT
stopped mitochondrial remodeling at the intermediate stage char-
acterized by tubular cristae. Thus, our results argue in favor of the
essential role of mitochondrial remodeling in cytochrome c release
induced by BAXoligo. Therefore, it seems likely that different factors,
which promote the mPT (e.g. Ca2+ and oxidative stress) and hence
favor mitochondrial remodeling, could facilitate BAXoligo-induced
cytochrome c release while factors, which inhibit the mPT could
impede the release of cytochrome c.
Previously, it was hypothesized that cytochrome c bound to the
outer surface of the IMM forms two distinct pools [22]. The “loosely
bound” cytochrome c appeared to be electrostatically attached to the
IMM via interaction with anionic lipids, mainly cardiolipin [58]. In
1420 T. Li et al. / Biochimica et Biophysica Acta 1777 (2008) 1409–1421addition, it has been proposed that some cytochrome c molecules are
anchored to the lipid membrane due to hydrophobic interactions and,
thus, form a pool of “tightly bound” cytochrome c, which represents
only about 10%of the total cytochrome c [32]. Peroxidationof cardiolipin
might disrupt the interaction between cytochrome c and cardiolipin,
increasing the fraction of “loosely bound” cytochrome c [59,60]. It was
proposed that “loosening” of cytochrome cmight serve as a ﬁrst step in
the process of cytochrome c release from isolated liver mitochondria
[22]. Hence, oxidative stress could amplify the release of cytochrome c
by increasing its detachment from the membrane. However, oxidative
stress could alsopromote themPT [37],whichwe found to be associated
with the cytochrome c release induced by BAXoligo in brain mitochon-
dria. The release of cytochrome c induced in our experiments either by
BAXoligo or by alamethicin was not accompanied by the increased
generation of ROS. On the contrary, the generation of ROS, which could
potentially cause lipid peroxidation, was drastically diminished. Never-
theless, alamethicin as well as BAXoligo resulted in a complete
cytochrome c release. Since this release proceeded without activation
of ROSgeneration, oxidative stress appeared toplaya dispensable role in
the BAXoligo-induced release of cytochrome c from brain mitochondria.
The experiments with replacement of the standard KCl-based medium
for the low-ionic strength mannitol-sucrose medium indicated that the
attachment of cytochrome c to the IMM is governed primarily by weak
electrostatic interactionswhich could be easily interrupted inhigh-ionic
strength KCl-based medium [31,32]. Consequently, it seems likely that
the massive release of cytochrome c induced by BAXoligo proceeds by a
mechanism involving permeabilization of the OMM accompanied by
mPT-dependent mitochondrial remodeling without necessity for
oxidative stress-dependent loosening of cytochrome c attachment to
the IMM.
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